Klavocin Dt (Amoxicillin, Clavulanic Acid)

Amoxicillin interferes with bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, leading to cell lysis. Clavulanic acid does not have strong antibacterial activity itself but inhibits β‑lactamase enzymes produced by resistant bacteria, preventing the breakdown of amoxicillin and extending its spectrum of activity.

The dosage of Klavocin Dt is individualized by the prescribing clinician based on the type and severity of infection, patient age, weight, renal function, and local prescribing guidelines. Healthcare professionals determine the appropriate strength, frequency, and duration for each patient.

The pregnancy safety category for amoxicillin/clavulanic acid is not definitively established. It should only be used during pregnancy or lactation when the expected benefit outweighs potential risks, and after consultation with a qualified obstetrician or pediatrician.

To request Klavocin Dt, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Plain amoxicillin lacks a β‑lactamase inhibitor, so it may be ineffective against organisms that produce β‑lactamase enzymes. Adding clavulanic acid in Klavocin Dt protects amoxicillin from enzymatic degradation, expanding coverage to include many resistant strains such as certain Haemophilus, Moraxella and Staphylococcus species.

Klavocin Dt should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use to maintain stability.

Klavocin Dt is taken orally, usually as tablets or oral suspension, with or without food as directed by the prescriber. The tablets should be swallowed whole with water; the suspension should be shaken well before measuring the dose with a calibrated device.

The most serious risks include severe allergic reactions such as anaphylaxis, life‑threatening skin conditions like Stevens‑Johnson syndrome or toxic epidermal necrolysis, Clostridioides difficile‑associated colitis, and significant liver injury. Patients should seek immediate medical attention if they experience symptoms such as rash, difficulty breathing, jaundice, or persistent diarrhea.

Klavocin Dt is contraindicated in individuals with a known hypersensitivity to amoxicillin, clavulanic acid, or any other β‑lactam antibiotics. Caution is also advised for patients with severe renal impairment who have not had dose adjustments, and for those with a history of severe liver disease or previous serious reactions to similar agents.